PALBOCICLIB 100MG

Description

Palbociclib – Targeted CDK4/6 Inhibitor for Breast Cancer

Palbociclib is a prescription targeted therapy and CDK4/6 inhibitor used in the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. By inhibiting the cyclin-dependent kinases 4 and 6 (CDK4/6), Palbociclib prevents cancer cells from progressing through the cell cycle, effectively slowing tumor growth.

At Oncomed Pharmacy, we provide authentic Palbociclib capsules from trusted manufacturers, ensuring patients receive safe, effective, and high-quality targeted therapy for breast cancer.

________________________________________

Key Features of Palbociclib

• Indications:

o Advanced or metastatic HR+/HER2- breast cancer in combination with aromatase inhibitors or fulvestrant

• Formulation: Oral capsules, commonly available in 75 mg, 100 mg, and 125 mg strengths.
• Mechanism of Action: Inhibits CDK4 and CDK6, blocking the transition from the G1 to S phase in the cell cycle, reducing cancer cell proliferation.
• Patient Benefit: Offers improved progression-free survival and a targeted treatment approach with manageable side effects compared to traditional chemotherapy.

________________________________________

Why Buy Palbociclib from Oncomed Pharmacy?

• 100% genuine and quality-tested targeted therapy.
• Multiple strengths available for personalized dosing.
• Competitive pricing with secure countrywide shipping.
• Trusted oncology pharmacy specializing in breast cancer therapies.

________________________________________

Uses of Palbociclib

• HR+/HER2- Advanced Breast Cancer:

o Combined with letrozole or other aromatase inhibitors for first-line therapy.

o Combined with fulvestrant in patients who have progressed on prior endocrine therapy.

• Provides a non-chemotherapy, targeted option for hormone receptor-positive breast cancer patients.

________________________________________